Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DAEWOONG PHARMA Logo
Develops and manufactures drugs, biologics, and active pharmaceutical ingredients.
South Korea
069620
DAIICHI SANKYO COMPANY, LIMITED Logo
A global healthcare company that researches and develops novel pharmaceutical solutions.
Japan
4568
Daito Pharmaceutical Co., Ltd. Logo
Integrated manufacturer of APIs and finished drugs for generic and OTC markets.
Japan
4577
Dare Bioscience, Inc. Logo
A clinical-stage biopharmaceutical company advancing innovative products for women's health.
United States of America
DARE
Day One Biopharmaceuticals, Inc. Logo
Commercial-stage company developing targeted cancer therapies, focusing on pediatrics.
United States of America
DAWN
DBV Technologies Logo
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
France
DBV
DBV Technologies S.A. Logo
A clinical-stage company developing epicutaneous immunotherapy for food allergies.
United States of America
DBVT
D&D Pharmatech Inc. Logo
Clinical-stage biopharma developing GLP-1 therapies for metabolic and neurodegenerative diseases.
South Korea
347850
Dechra Pharmaceuticals PLC Logo
A global specialist in veterinary pharmaceuticals and related products.
United Kingdom
DPH
DELCATH SYSTEMS, INC. Logo
Interventional oncology company treating liver cancers with targeted chemotherapy.
United States of America
DCTH

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.